These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 3984856)

  • 1. Marketing and distribution of pharmaceuticals in the 21st century: two scenarios.
    Hoff LC
    Am Pharm; 1985 Mar; NS25(3):70-6. PubMed ID: 3984856
    [No Abstract]   [Full Text] [Related]  

  • 2. [The advertisement is a mirror of history. Progress and curiosities blended].
    Lennholm B
    Lakartidningen; 2004 Jan; 101(1-2):40-5. PubMed ID: 14763001
    [No Abstract]   [Full Text] [Related]  

  • 3. The pharmacist: key player in the home health market.
    Huston P
    Med Mark Media; 1985 Jul; 20(7):8-9, 12-21. PubMed ID: 10272850
    [No Abstract]   [Full Text] [Related]  

  • 4. The changing role of pharmacies in the 1990s.
    Tootelian DH; Gaedeke RM
    J Health Care Mark; 1986 Mar; 6(1):57-63. PubMed ID: 10276833
    [No Abstract]   [Full Text] [Related]  

  • 5. Managed competition. Using market incentives to control costs, quality.
    Durenberger D
    Minn Med; 1994 Sep; 77(9):25-6. PubMed ID: 7968950
    [No Abstract]   [Full Text] [Related]  

  • 6. Not as easy as it may appear: using radio frequency identification technology to fulfill the Prescription Drug Marketing Act's elusive pedigree requirement.
    Asamoah AK
    Food Drug Law J; 2006; 61(2):385-418. PubMed ID: 16903035
    [No Abstract]   [Full Text] [Related]  

  • 7. Transitioning health care marketing into the twenty-first century.
    Rynne TJ
    Mark Health Serv; 1999; 19(2):10-4. PubMed ID: 10557749
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Scenarios for 21st-century health care in the United States of America: perspectives on time and change.
    Bezold C
    World Health Stat Q; 1994; 47(3-4):126-39. PubMed ID: 7740827
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The evolutionary eighties: pharmacy, a profession in transition.
    Walton CA
    Am J Pharm Educ; 1978 Dec; 42(5):440-7. PubMed ID: 10240760
    [No Abstract]   [Full Text] [Related]  

  • 10. Pharmacists, pharmaceuticals, and drug information in the 21st century.
    Schondelmeyer SW
    Drug Inf J; 1985; 19(2):185-93. PubMed ID: 10272204
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Niche marketing: it's good for business.
    Menighan TE
    Am Pharm; 1991 Feb; NS31(2):51. PubMed ID: 2006612
    [No Abstract]   [Full Text] [Related]  

  • 12. The political economy of pharmaceutical marketing channels: a conceptual framework.
    Doucette WR; Schommer JC; Wiederholt JB
    Clin Ther; 1993; 15(4):739-51. PubMed ID: 8221824
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmaceutical industry restructuring and new marketing approaches: enforcement responses.
    Mahinka SP; Sanzo KM
    Food Drug Law J; 1995; 50(2):313-25. PubMed ID: 10343000
    [No Abstract]   [Full Text] [Related]  

  • 14. A framework for the practice of pharmacy in the 21st century.
    Penna P
    Manag Care Interface; 2002 Feb; 15(2):63-4. PubMed ID: 11875963
    [No Abstract]   [Full Text] [Related]  

  • 15. Let marketplace regulate specialization.
    Burke EC
    Minn Med; 1993 Apr; 76(4):5. PubMed ID: 8515737
    [No Abstract]   [Full Text] [Related]  

  • 16. Designs of the future: dispensing in the 21st century.
    Barker KN; Pearson RE; Swensson ES
    Am J Pharm Educ; 1986; 50(4):362-8. PubMed ID: 10281193
    [No Abstract]   [Full Text] [Related]  

  • 17. The University Hospital. Will new strategies keep it in the game?
    Moriarity J
    Minn Med; 1993 Apr; 76(4):16-23. PubMed ID: 8515732
    [No Abstract]   [Full Text] [Related]  

  • 18. Drug information databases for the 21st century: a review of the most popular applications.
    Zeolla M; Lipke AA; Geller B; Abourjaily H; Rosenberg M
    J Mass Dent Soc; 2002; 51(1):52-5. PubMed ID: 11949578
    [No Abstract]   [Full Text] [Related]  

  • 19. Data and market exclusivity for pharmaceuticals in the European Community.
    Kingham RF; Castle GH
    Food Drug Law J; 2000; 55(2):209-23. PubMed ID: 12269365
    [No Abstract]   [Full Text] [Related]  

  • 20. Health care costs: market forces and reform.
    Vincenzino JV
    Stat Bull Metrop Insur Co; 1995; 76(1):29-35. PubMed ID: 7624822
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.